Joseph Bertelse – PharmaTimes

Nuclera has appointed Joseph Bertelsen as Chief Commercial Officer

Nuclera has announced the appointment of Joseph Bertelsen as Chief Commercial Officer.

With over 20 years’ commercial leadership experience in the life sciences tools and drug development industries, Joseph brings an extensive sales record that will be instrumental to the commercial launch of the company’s eProtein Discovery platform. 

Joseph joins Nuclera from the Institute for Protein Innovation, a research institute focused on providing synthetic antibodies, where he was the Director of Commercialisation responsible for establishing a sustainable antibody distribution entity.

Prior roles include SVP of Global Sales and Marketing at Diagenode, a life sciences company providing tools for molecular epigenetics research and infectious disease diagnostics, and Director of Sales at Abcam, a company specialising in the production and distribution of research antibodies.

Joseph enthused: “Nuclera is disrupting the protein market with their technology allowing researchers to more easily and quickly have access to proteins for their research. Their benchtop technology has the potential to greatly reduce costs and timelines associated with the drug discovery process.”